Pyrimido[1,2-a]benzimidazoles as inhibitors of oncoproteins ubiquitin specific protease 5 and MYCN in the childhood cancer neuroblastoma
- 29 March 2023
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 136, 106462
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastomaNucleic Acids Research, 2013
- Regiodirected synthesis of polyfluoro-alkylated pyrimido[1,2-a]benzimidazolesChemistry of Heterocyclic Compounds, 2012
- Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitorsClinical Epigenetics, 2012
- PTBP1‐dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesisMolecular Carcinogenesis, 2011
- Molecular Interaction Studies Using Microscale ThermophoresisASSAY and Drug Development Technologies, 2011
- SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein StabilityPLOS Genetics, 2011
- Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53Journal of Biological Chemistry, 2009
- Trifluoromethyl ethers – synthesis and properties of an unusual substituentBeilstein Journal of Organic Chemistry, 2008
- EXPRESSION OF CONCERN: Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cellsBritish Journal of Pharmacology, 2008
- Synthesis and Characterization of Some Novel 2-(Trifluoromethyl)pyrimido[1,2-a]benzimidazoles and Pyrimido[1,2-a]benzimidazol-2H)-ones of Biological InterestSynthesis, 2006